etoposide has been researched along with propiconazole in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (11.11) | 18.2507 |
2000's | 3 (33.33) | 29.6817 |
2010's | 5 (55.56) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abramson, DH; Dunkel, IJ; Madden, T; Mendelsohn, ME; Tong, W; Tran, HT | 1 |
Balayre, S; Dighiero, P; Gicquel, JJ; Mercie, M | 1 |
Hanada, R; Horibe, K; Kobayashi, R; Tawa, A; Tsuchida, M; Tsukimoto, I | 1 |
Erkan Balci, K; Güler, G; Kiratli, H | 1 |
Belaïch, H; Gentet, JC; Michel, G; Nicollas, R; Roman, S; Rome, A; Triglia, JM; Volk, M | 1 |
Fishman, M; Kim, JW; Moshfeghi, D; Yau, JW | 1 |
Bakhshi, S; Radhakrishnan, V; Sharma, S; Vishnubhatla, S | 1 |
Chen, CI; Chu, CM; Cserti-Gazdewich, C; Jiang, H; Jimenez-Zepeda, VH; Kukreti, V; Masih-Khan, E; Rabea, A; Reece, DE; Tiedemann, R; Trudel, S; Tsang, R | 1 |
Díaz-Llopis, M; España-Gregori, E; Hernández-Martínez, P; Hervás-Ontiveros, A; Vera-Sempere, FJ | 1 |
1 trial(s) available for etoposide and propiconazole
Article | Year |
---|---|
Head and neck manifestation and prognosis of Langerhans' cell histiocytosis in children.
Topics: Adolescent; Anti-Inflammatory Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bone Diseases; Child; Child, Preschool; Drug Therapy, Combination; Etoposide; Female; Frontal Bone; Histiocytosis, Langerhans-Cell; Humans; Infant; Interdisciplinary Communication; Male; Neck; Orbit; Parietal Lobe; Patient Care Team; Prednisone; Prognosis; Retrospective Studies; Temporal Bone; Tomography, X-Ray Computed; Treatment Outcome; Vinblastine | 2010 |
8 other study(ies) available for etoposide and propiconazole
Article | Year |
---|---|
Intraocular concentrations of chemotherapeutic agents after systemic or local administration.
Topics: Absorption; Administration, Topical; Animals; Antineoplastic Agents; Aqueous Humor; Biological Availability; Carboplatin; Etoposide; Infusions, Intravenous; Injections; Macaca fascicularis; Ophthalmic Solutions; Orbit; Tissue Distribution; Vincristine; Vitreous Body | 1998 |
[Orbital extension of sinus plasmacytoma secondarily transforming into multiple myeloma: a case study].
Topics: Adult; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cyclophosphamide; Dexamethasone; Diplopia; Doxorubicin; Ethmoid Sinus; Etoposide; Exophthalmos; Humans; Male; Maxillary Sinus; Maxillary Sinus Neoplasms; Methylprednisolone Hemisuccinate; Multiple Myeloma; Orbit; Orbital Neoplasms; Paranasal Sinus Neoplasms; Plasmacytoma; Tomography, X-Ray Computed; Treatment Outcome; Vincristine; Visual Acuity | 2004 |
Extramedullary infiltration at diagnosis and prognosis in children with acute myelogenous leukemia.
Topics: Acute Disease; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone and Bones; Central Nervous System; Child; Child, Preschool; Cytarabine; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Gingiva; Humans; Hydrocortisone; Idarubicin; Infant; Infant, Newborn; Japan; Kaplan-Meier Estimate; Leukemia, Myeloid; Leukemic Infiltration; Male; Methotrexate; Orbit; Prognosis; Remission Induction; Sarcoma, Myeloid; Skin; Testis | 2007 |
Primary orbital endodermal sinus tumor (yolk sac tumor).
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child, Preschool; Cisplatin; Endodermal Sinus Tumor; Etoposide; Female; Humans; Magnetic Resonance Imaging; Orbit; Orbital Neoplasms; Treatment Outcome | 2008 |
Orbital fibrosis and intraocular recurrence of retinoblastoma following periocular carboplatin.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Eye Enucleation; Female; Fibrosis; Humans; Infant; Injections, Intraocular; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Neoplasm Seeding; Orbit; Retinal Neoplasms; Retinoblastoma; Tomography, X-Ray Computed; Vincristine | 2010 |
MRI findings at baseline and after neoadjuvant chemotherapy in orbital retinoblastoma (IRSS stage III).
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Disease-Free Survival; Etoposide; Eye Enucleation; Female; Humans; Magnetic Resonance Imaging; Male; Neoadjuvant Therapy; Neoplasm Staging; Optic Nerve Neoplasms; Orbit; Prospective Studies; Radiotherapy, High-Energy; Retinal Neoplasms; Retinoblastoma; Survival Rate; Vincristine | 2013 |
Central nervous system involvement with multiple myeloma: long term survival can be achieved with radiation, intrathecal chemotherapy, and immunomodulatory agents.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Central Nervous System; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Dexamethasone; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunologic Factors; Injections, Spinal; Kaplan-Meier Estimate; Lenalidomide; Male; Meninges; Middle Aged; Multiple Myeloma; Orbit; Proportional Hazards Models; Pyrazines; Radiotherapy, Adjuvant; Retrospective Studies; Salvage Therapy; Spine; Thalidomide; Transplantation, Autologous; Treatment Outcome; Vincristine | 2013 |
Orbital involvement by non-Hodgkin lymphoma NK T cells.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Marrow; Cisplatin; Cytarabine; Ethmoid Sinus; Etoposide; Exophthalmos; Fatal Outcome; Humans; Lymphoma, Extranodal NK-T-Cell; Male; Maxillary Sinus; Methylprednisolone; Nasal Obstruction; Neoplasm Recurrence, Local; Orbit; Salvage Therapy; Tomography, X-Ray Computed | 2014 |